A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer

DOI Full Paper Access

35

Citations

28

References

2010

Year

Athanasios Pallis, Athina Agelidou, Ioannis Varthalitis, Kostas Syrigos, Nikolaos Kentepozidis, Georgia Pavlakou, Αthanasios Kotsakis, E. Kontopodis, Vassilis Georgoulias

References

	Year	Citations

Page 1